Prestige Consumer Healthcare

PBHNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.111 B

$44.57 -16.36%

Close of 6 Nov 2026

As of 6 Nov 2026, Prestige Consumer Healthcare (PBH) has a market capitalization of $2.11B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.09B

#1470 by revenue

Earnings

$190.3M

#1016 by earnings

Shares outstanding

47,397,106

Latest filing cover page

P/E ratio

11.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#92SchrodingerSDGR$2.16B
#93ImmunomeIMNM$2.13B
#94Prestige Consumer HealthcarePBH$2.11B
#95BiohavenBHVN$2.09B
#96ZymeworksZYME$2.03B

What if Prestige Consumer Healthcare were worth as much as…

Open the what-if tool →

Gold $28.2T

$596,035.01

Per share 13,375× higher

Bitcoin $1.53T

$32,250.42

Per share 724× higher

Apple $5.02T

$105,875.11

Per share 2,376× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Prestige Consumer Healthcare are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.